(function(){ var content_array=["

鍏充簬<\/i>SoliD<\/i>鐮旂┒锛堢鐭崇爺绌讹級<\/i>1<\/sup><\/i><\/p> \n

SoliD纾愮煶鐮旂┒锛圢CT05413369锛夐拡瀵� 582 鍚嶆帴鍙楄嚦澶氫袱绉嶅彛鏈嶉檷绯栬嵂娌荤枟琛€绯栨帶鍒朵笉浣崇殑2鍨嬬硸灏跨梾鎮ｈ€咃紙HbA1c锛�7-11%锛夛紝姣旇緝浜嗙敇绮捐儼宀涚礌鍒╁徃閭ｈ偨涓庡痉璋烽棬鍐儼宀涚礌鐨勭枟鏁堝拰瀹夊叏鎬с€傚彈璇曡€呭湪闅忔満鍒嗙粍鍚庡仠鐢ㄩ櫎浜岀敳鍙岃儘鍙奡GLT-2i澶栫殑鍏朵粬鍙ｆ湇闄嶇硸鑽€傚湪杩欓」寮€鏀炬爣绛剧殑鐮旂┒涓紝鍙楄瘯鑰呬互1:1鐨勬瘮渚嬮殢鏈哄叆缁勶紝鍦ㄤ簩鐢插弻鑳�±SGLT-2i鐨勫熀纭€涓婂姞鍏ョ敇绮捐儼宀涚礌鍒╁徃閭ｈ偨鎴栧痉璋烽棬鍐紝鎸佺画24鍛ㄣ€傝繖鏄涓敇绮惧埄鍙镐笌寰疯胺闂ㄥ啲鐨勫ご瀵瑰ご闅忔満瀵圭収涓村簥璇曢獙锛屼篃鏄畬鍏ㄨ仛鐒︿腑鍥芥偅鑰呯殑鐗硅壊鐮旂┒銆�<\/p> \n

鐢樼簿鑳板矝绱犲埄鍙搁偅鑲借揪鍒扮爺绌朵富瑕佺粓鐐癸紝鐢樼簿鑳板矝绱犲埄鍙搁偅鑲戒笌寰疯胺闂ㄥ啲鐩告瘮锛岃嚜鍩虹嚎鑷�24鍛紙鏈€灏忎簩涔樻硶锛圠S锛夛級鐨凥bA1c闄嶅箙杩涗竴姝ヤ笅闄�0.2% (95%缃俊鍖洪棿[CI]: -0.33鑷�-0.07%; p < 0.001)锛岀粺璁″闈炲姡鏁堣揪鎴愶紝杩涗竴姝ヨ揪鎴愪紭鏁堟€�(97.5% CI: 鈭�0.35鑷斥垝0.05%; p=0.003)銆�<\/p> \n

浣庤绯栦簨浠剁巼鍩轰簬缇庡浗绯栧翱鐥呭崗浼氾紙ADA锛夊垎绫荤殑1銆�2鎴�3绾ф爣鍑嗭紝鐢樼簿鑳板矝绱犲埄鍙搁偅鑲界粍锛�1.90姣忔偅鑰呭勾锛夋瘮寰疯胺闂ㄥ啲缁勶紙2.72姣忔偅鑰呭勾锛夋€讳綋闄嶄綆29%锛堢浉瀵归闄╋細0.71锛�95% CI锛�0.52鑷�0.98锛夈€傜爺绌舵湭鎶ュ憡涓ラ噸鐨勪綆琛€绯栦簨浠讹紙闇€瑕佸閮ㄥ崗鍔╋紝ADA 3 绾э級鎴栨剰澶栫殑瀹夊叏鎬у彂鐜般€�<\/p> \n

绗�24鍛ㄧ敇绮捐儼宀涚礌鍒╁徃閭ｈ偨缁勫彈璇曡€呯殑浣撻噸鍧囧€艰緝鍩虹嚎杩涗竴姝ヤ笅闄嶏紝鑰屽痉璋烽棬鍐粍鍙楄瘯鑰呯殑浣撻噸鍧囧€煎垯鍑虹幇澧為暱锛屽鑷碙S鍧囧€煎樊涓�-1.5鍏枻锛�97.5% CI锛�-2.32鑷�-0.66; p<0.001锛夈€�<\/p> \n

鍦ㄧ24鍛ㄥ弽鏄犳不鐤楃洰鏍囪揪鎴愮殑鍏朵粬娆¤缁堢偣涓婏紝鐢樼簿鑳板矝绱犲埄鍙搁偅鑲藉悓鏍蜂紭浜庡痉璋烽棬鍐細<\/p> \n

\n \n \n \n \n \n \n

鍏抽敭娆¤缁堢偣<\/b><\/span><\/p> <\/td> \n

鐢樼簿鍒╁徃<\/b><\/span><\/p> <\/td> \n

寰疯胺闂ㄥ啲<\/b><\/span><\/p> <\/td> \n

P<\/b>鍊�<\/b><\/span><\/p> <\/td> \n <\/tr> \n

HbA1c<7.0%<\/span><\/p> <\/td> \n

72.5 %<\/span><\/p> <\/td> \n

59.8 %<\/span><\/p> <\/td> \n

< 0.001<\/span><\/p> <\/td> \n <\/tr> \n

HbA1c<7<\/span>.0<\/span>% <\/span><\/p>

鏃犱綋閲嶅鍔�<\/span><\/p> <\/td> \n

40.5 %<\/span><\/p> <\/td> \n

21.3 %<\/span><\/p> <\/td> \n

< 0.001<\/span><\/p> <\/td> \n <\/tr> \n

HbA1c<7.0% <\/span><\/p>

鏃犱綋閲嶅鍔狅紝鏃犱綆琛€绯栦簨浠�<\/span><\/p> <\/td> \n

26.5 %<\/span><\/p> <\/td> \n

13.4 %<\/span><\/p> <\/td> \n

< 0.001<\/span><\/p> <\/td> \n <\/tr> \n <\/tbody> \n <\/table> \n<\/div> \n

 <\/p> \n

鐢樼簿鑳板矝绱犲埄鍙搁偅鑲芥敞灏勬恫锛圛锛塡/锛圛I锛夊凡浜�2023骞�1鏈堣幏鎵癸紝閫傜敤浜庤绯栨帶鍒朵笉浣崇殑鎴愪汉2鍨嬬硸灏跨梾鎮ｈ€咃紝鍦ㄩギ椋熷拰杩愬姩鍩虹涓婅仈鍚堝叾浠栧彛鏈嶉檷绯栬嵂鐗╋紝鏀瑰杽琛€绯栨帶鍒躲€傝鑽凡鍦�2023骞村簳琚撼鍏ャ€婂浗瀹跺熀鏈尰鐤椾繚闄┿€佸伐浼や繚闄╁拰鐢熻偛淇濋櫓鑽搧鐩綍銆嬶紝骞跺湪銆婁腑鍥借€佸勾绯栧翱鐥呰瘖鐤楁寚鍗楋紙2024鐗堬級銆嬩腑棣栨琚撼鍏ュ埌鑰佸勾鎮ｈ€呯畝鍖栨不鐤楃殑閫夋嫨涔嬩竴锛屽湪闈炶儼宀涚礌娌荤枟涓嶈揪鏍囧悗鐨勬不鐤楄矾寰勪腑寰楀埌涓€绾ф帹鑽�7<\/sup>銆�<\/p> \n

*<\/b>鐢樼簿鑳板矝绱犲埄鍙搁偅鑲藉鏂瑰埗鍓傦紝绠€绉颁负鐢樼簿鍒╁徃
<\/b> 寰疯胺闂ㄥ啲鍙岃儼宀涚礌锛岀畝绉颁负寰疯胺闂ㄥ啲<\/b><\/p> \n

References<\/i><\/p> \n

鍙傝€冩枃鐚�<\/b><\/p> \n

\n \n \n \n \n \n \n \n \n \n

[1]<\/sup><\/span>  Liu M., et al. Efficacy and Safety of iGlarLixi vs IDegAsp in Chinese People with Type 2 Diabetes (T2D) Suboptimally Controlled with Oral Antidiabetic Drug(s) (OAD): The SoliD Randomized Controlled Trial, Abstract #1869-LB, American Diabetes Association 84th<\/sup><\/span> Scientific Sessions, June 21-24, 2024, Orlando, Florida, U.S.A.<\/p> <\/td> \n <\/tr> \n

[2]<\/sup><\/span>  Ming L., et al. The efficacy and safety of iGlarLixi versus IDegAsp in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The SoliD randomized controlled trial, Diab. Obes. & Metab.<\/i> [full citation to be provided by Medical, when timing of publication is confirmed]<\/p> <\/td> \n <\/tr> \n

[3]<\/sup><\/span>  Jude E., et al. Effectiveness of premix insulin in type 2 diabetes: a retrospective UK cohort study.<\/p> <\/td> \n <\/tr> \n

[4]<\/sup><\/span>  绾珛鍐滅瓑. "浣跨敤鍙ｆ湇闄嶇硸鑽绯栨帶鍒舵瑺浣崇殑涓浗T2DM鎮ｈ€呰捣濮嬭儼宀涚礌娌荤枟鐜扮姸."涓浗绯栧翱鐥呮潅蹇� 19.10:6<\/p> <\/td> \n <\/tr> \n

[5]<\/sup><\/span>  Liu G, et al. Diabetes Metab Syndr Obes 2020,13:4651-4659.<\/p> <\/td> \n <\/tr> \n

[6]<\/sup><\/span>  Jude E., et al. Effectiveness of premix insulin in type 2 diabetes: a retrospective UK cohort study. Diabetes Obes Metab. 2021;23:929-937.<\/p> <\/td> \n <\/tr> \n

[7]<\/sup><\/span>  鍥藉鑰佸勾鍖诲涓績, 涓崕鍖诲浼氳€佸勾鍖诲鍒嗕細, 涓浗鑰佸勾淇濆仴鍗忎細绯栧翱鐥呬笓涓氬鍛樹細. 涓浗鑰佸勾绯栧翱鐥呰瘖鐤楁寚鍗楋紙2024鐗堬級 [J] . 涓崕绯栧翱鐥呮潅蹇�, 2024, 16(2) : 147-189. DOI: 10.3760\/cma.j.cn115791-20240112-00020.<\/p> <\/td> \n <\/tr> \n <\/tbody> \n <\/table> \n<\/div> \n

 <\/p> \n

 <\/p>"]; $("#dvExtra").html(content_array[0]);})();